{"nct_id":"NCT02236611","title":"A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2014-09-26","start_date_type":"ACTUAL","primary_completion_date":"2015-06-02","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-02","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}